{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T08:33:56Z","timestamp":1723106036142},"reference-count":8,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2019,5,22]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Atypical antipsychotics, unlike traditional antipsychotics, are considered to\nhave limited cardiovascular side effects, but recent evidence drew attention to potential cardiac rhythm\ndisturbances during aripiprazole therapy. Prolonged QT-interval and increased heart rate were described\nduring treatment with therapeutic doses of aripiprazole, and some reports have even shown relevant\narrhythmias, such as ventricular trigeminy and supraventricular tachycardia, in patients treated\nwith this drug.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Report:<\/jats:title>\n<jats:p>Here, we report a case of a young female who attempted suicide with aripiprazole overdose\npresenting with a concomitant 2:1 second degree atrioventricular block. Little is known on the\ncardiac toxicity of atypical antipsychotics in overdose: reporting this case description, far from establishing\ndirect causality.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results and Conclusion:<\/jats:title>\n<jats:p> We would promote further efforts to define the possible effects of the drug\non the cardiac conduction system, for a safer management of patients in clinical practice.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886314666190119120657","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T14:34:43Z","timestamp":1547908483000},"page":"155-157","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aripiprazole Overdose and Transient 2:1 Second Degree Atrioventricular Block: Only A Coincidence?"],"prefix":"10.2174","volume":"14","author":[{"given":"Lucia","family":"Russo","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Internal Medicine, University Hospital of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Di Vincenzo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Internal Medicine, University Hospital of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences, Cardiology Clinic, University Hospital of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Rossato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Internal Medicine, University Hospital of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Vettor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Internal Medicine, University Hospital of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612043383872","volume":"10","author":"Pacher P.","year":"2004","unstructured":"Pacher P, Kecskemeti V. Curr Pharm Des, Cardiovascular side effects of new antidepressants and antipsychotics: New drugs, old concerns?,, 2004, 10,, 2463-2475,","journal-title":"Curr Pharm Des"},{"key":"ref=2","unstructured":"US Food and Drug Administration. Available from:, .  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/02143 6s038,021713s030,021729s022,021866s023lbl.pdf, , ,"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/heartjnl-2012-303220","volume":"99","author":"Alboni P.","year":"2013","unstructured":"Alboni P, Holz A, Brignole M. Heart, Vagally mediated atrioventricular block: Pathophysiology and diagnosis.,, 2013, 99,, 904-908,","journal-title":"Heart"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/JCP.0000000000000577","volume":"36","author":"Belmonte C.","year":"2016","unstructured":"Belmonte C, Ochoa D, Rom\u00e1n M. J Clin Psychopharmacol, Evaluation of the relationship between pharmacokinetics and the safety of aripiprazole and its cardiovascular effects in healthy volunteers.,, 2016, 36,, 608-614,","journal-title":"J Clin Psychopharmacol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.2147\/NDT.S91771","volume":"11","author":"Shao Q.","year":"2015","unstructured":"Shao Q, Quan W, Jia X, Chen J, Ma S, Zhang X. Neuropsychiatr Dis Treat, Severe arrhythmia induced by orally disintegrating aripiprazole tablets (Bosiqing \u00ae): A case report.,, 2015, 11,, 3019-3021,","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.jcp.0000231267.94210.e5","volume":"26","author":"Egger C.","year":"2006","unstructured":"Egger C, Rauscher A, Muehlbacher M, Nickel M, Geretsegger C, Stuppaeck C. J Clin Psychopharmacol, A case of dose-dependent aripiprazole-induced conduction disturbance.,, 2006, 26,, 436-,","journal-title":"J Clin Psychopharmacol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1819.2008.01833.x","volume":"62","author":"Torgovnick J.","year":"2008","unstructured":"Torgovnick J, Sethi NK, Arsura E. Psychiatry Clin Neurosci, Aripiprazole-induced orthostatic hypotension and cardiac arrhythmia.,, 2008, 62,, 485-,","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1037\/pha0000219","volume":"26","author":"D\u2019Urso G.","year":"2018","unstructured":"D\u2019Urso G, Anastasia A, Toscano E, Patti S, de Bartolomeis A. Exp Clin Psychopharmacol, Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors.,, 2018, 26,, 509-513,","journal-title":"Exp Clin Psychopharmacol"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T07:14:23Z","timestamp":1573715663000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169165\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886314666190119120657","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}